Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

481 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission.
Wei AH, Döhner H, Pocock C, Montesinos P, Afanasyev B, Dombret H, Ravandi F, Sayar H, Jang JH, Porkka K, Selleslag D, Sandhu I, Turgut M, Giai V, Ofran Y, Kizil Çakar M, Botelho de Sousa A, Rybka J, Frairia C, Borin L, Beltrami G, Čermák J, Ossenkoppele GJ, La Torre I, Skikne B, Kumar K, Dong Q, Beach CL, Roboz GJ; QUAZAR AML-001 Trial Investigators. Wei AH, et al. Among authors: turgut m. N Engl J Med. 2020 Dec 24;383(26):2526-2537. doi: 10.1056/NEJMoa2004444. N Engl J Med. 2020. PMID: 33369355 Clinical Trial.
Mantle cell lymphoma: a Turkish Multi-Center Study.
Okay M, Meletli O, Kelkitli E, Malkan UY, Turgut M, Buyukasik Y, Tekin F, Demiroglu H, Goker H. Okay M, et al. Among authors: turgut m. J BUON. 2019 Sep-Oct;24(5):2084-2089. J BUON. 2019. PMID: 31786879 Free article.
Allogeneic Hematopoietic Stem-Cell Transplantation Improves Disease-Free Survival Compared to Pediatric-Inspired Berlin-Frankfurt-Münster Chemotherapy in Adult Acute Lymphoblastic Leukemia.
Aladag E, Aktimur SH, Aydın Ö, Demiroglu H, Buyukasik Y, Aksu S, Ozcebe OI, Haznedaroglu IC, Sayinalp N, Turgut M, Goker H. Aladag E, et al. Among authors: turgut m. Clin Lymphoma Myeloma Leuk. 2021 Mar;21(3):147-153. doi: 10.1016/j.clml.2020.12.014. Epub 2021 Jan 12. Clin Lymphoma Myeloma Leuk. 2021. PMID: 33451957
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis.
Kastritis E, Palladini G, Minnema MC, Wechalekar AD, Jaccard A, Lee HC, Sanchorawala V, Gibbs S, Mollee P, Venner CP, Lu J, Schönland S, Gatt ME, Suzuki K, Kim K, Cibeira MT, Beksac M, Libby E, Valent J, Hungria V, Wong SW, Rosenzweig M, Bumma N, Huart A, Dimopoulos MA, Bhutani D, Waxman AJ, Goodman SA, Zonder JA, Lam S, Song K, Hansen T, Manier S, Roeloffzen W, Jamroziak K, Kwok F, Shimazaki C, Kim JS, Crusoe E, Ahmadi T, Tran N, Qin X, Vasey SY, Tromp B, Schecter JM, Weiss BM, Zhuang SH, Vermeulen J, Merlini G, Comenzo RL; ANDROMEDA Trial Investigators. Kastritis E, et al. N Engl J Med. 2021 Jul 1;385(1):46-58. doi: 10.1056/NEJMoa2028631. N Engl J Med. 2021. PMID: 34192431 Clinical Trial.
CD34+ hematopoietic progenitor cell dose as a predictor of engraftment and survival in multiple myeloma patients undergoing autologous stem cell transplantation.
Aladağ Karakulak E, Demiroğlu H, Büyükaşik Y, Turgut M, Aksu S, Sayinalp N, Haznedaroğlu IC, Özcebe OI, Göker H. Aladağ Karakulak E, et al. Among authors: turgut m. Turk J Med Sci. 2020 Dec 17;50(8):1851-1856. doi: 10.3906/sag-2001-173. Turk J Med Sci. 2020. PMID: 32512672 Free PMC article.
Prophylactic Central Nervous System Irradiation Is Not Indispensable in Adult Patients with Acute Lymphoblastic Leukemia: A Multicenter Retrospective Cohort Study.
Çınar OE, Göker H, Fidan K, Aydın Ö, Pashayev T, Malkan ÜY, Velet M, Büyükaşık Y, Aksu S, Özcebe Oİ, Haznedaroğlu İC, Sayınalp N, Vural F, Turgut M, Ünal A, Demiroğlu H. Çınar OE, et al. Among authors: turgut m. Turk J Haematol. 2022 Aug 25;39(3):152-159. doi: 10.4274/tjh.galenos.2022.2021.0680. Epub 2022 Apr 21. Turk J Haematol. 2022. PMID: 35445593 Free PMC article.
The effect of comorbidities on the choice of tyrosine kinase inhibitors in patients with chronic myeloid leukemia.
Saydam G, Ali R, Demir AM, Eskazan AE, Guvenc B, Haznedaroglu IC, Ozcan MA, Salim O, Sonmez M, Tuglular AT, Turgut M, Unal A, Aver B, Bozkurt S, Ozdengulsun B, Ilhan O. Saydam G, et al. Among authors: turgut m. Int J Hematol Oncol. 2022 May 24;11(1):IJH38. doi: 10.2217/ijh-2021-0010. eCollection 2022 Mar. Int J Hematol Oncol. 2022. PMID: 35664044 Free PMC article. Review.
Patterns of Hydroxyurea Prescription and Use in Routine Clinical Management of Polycythemia Vera: A Multicenter Chart Review Study.
Büyükaşık Y, Ali R, Turgut M, Saydam G, Yavuz AS, Ünal A, Ar MC, Ayyıldız O, Altuntaş F, Okay M, Çiftçiler R, Meletli Ö, Soyer N, Mastanzade M, Güven Z, Soysal T, Karakuş A, Yiğenoğlu TN, Uçar B, Gökçen E, Tuğlular T. Büyükaşık Y, et al. Among authors: turgut m. Turk J Haematol. 2020 Aug 28;37(3):177-185. doi: 10.4274/tjh.galenos.2020.2019.0431. Epub 2020 Feb 20. Turk J Haematol. 2020. PMID: 32075363 Free PMC article.
Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial.
Moreau P, Dimopoulos MA, Mikhael J, Yong K, Capra M, Facon T, Hajek R, Špička I, Baker R, Kim K, Martinez G, Min CK, Pour L, Leleu X, Oriol A, Koh Y, Suzuki K, Risse ML, Asset G, Macé S, Martin T; IKEMA study group. Moreau P, et al. Lancet. 2021 Jun 19;397(10292):2361-2371. doi: 10.1016/S0140-6736(21)00592-4. Epub 2021 Jun 4. Lancet. 2021. PMID: 34097854 Clinical Trial.
481 results